Drug intelligence / Profile preview

gamma-tocopherol-rich tocopherol mixture

Development stage
Unknown
Lead developer
Rutgers University
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

gamma-tocopherol-rich tocopherol mixture (γ-TmT) is a natural product mixture composed of various forms of vitamin E, typically containing approximately 57% gamma-tocopherol, 24% delta-tocopherol, 13% alpha-tocopherol, and 1.5% beta-tocopherol. Derived as a by-product of vegetable oil refining, γ-TmT has been investigated preclinically and clinically for its anti-inflammatory, anti-oxidative, and anti-carcinogenic properties. It has demonstrated efficacy in animal models of colon, lung, mammary, and prostate cancers, as well as colon inflammation, and has been evaluated in early-phase clinical trials for asthma, airway inflammation, and prostate cancer. Its mechanism of action involves the inhibition of cyclooxygenase-1 (COX-1), cyclooxygenase-2 (COX-2), and 5-lipoxygenase (5-LOX), leading to a reduction in inflammatory mediators such as prostaglandin E2 (PGE2) and leukotriene B4 (LTB4). Additionally, γ-TmT traps reactive nitrogen species, reduces oxidative stress, and modulates downstream signaling pathways (including Nrf2, PTEN, AKT, and Caspase-3) to induce apoptosis and inhibit cell proliferation in cancer cells.

Brand names
Advanced High Gamma Vitamin E
Other names
gamma-tocopherol-rich mixture of tocopherols
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)ALOX12 (Arachidonate 12-lipoxygenase, 12S type)NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)

Beyond the preview

Go deeper on gamma-tocopherol-rich tocopherol mixture.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on gamma-tocopherol-rich tocopherol mixture.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call